Wow, I have to agree there is so much going on here, starting with the country selection for this trial. Prior to selecting Thailand I think the Sponsor should have started dialogue with stakeholders in different potential countries and from those discussions make the most public health AND ethical based decision. Based on the information they would have received I am fairly confident that Thailand would not have been on the final list of countries or the sole country for this trial. Yes and I also would be concerned about the legitimacy of the data from this study. Definitely a bad way of conducting trials on the part of the Sponsor.